DCM
GH icon

Discovery Capital Management’s Guardant Health GH Stock Holding History

Discovery Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-75,000
Closed -$6.08M – 69
2020
Q2 		$6.08M Buy
+75,000
New +$6.04M 1.11% 25

Other funds holding GH

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Discovery Capital Management's GH Position: Q3 2020 in Review

Discovery Capital Management sold out of Guardant Health (GH) in Q3 2020, closing a stake of 75,000 shares — an estimated $6.08M sold.

Discovery Capital Management first reported a position in GH in Q2 2020 and held it in 1 quarter. The position peaked at $6.08M in Q2 2020. 346 funds tracked by Wall St. Rank hold GH as of Q3 2020.

  • Discovery Capital Management reported no remaining Guardant Health position as of Q3 2020 after selling out during the quarter.
  • Discovery Capital Management sold 75,000 Guardant Health shares in Q3 2020, an estimated $6.08M.
  • Discovery Capital Management first reported a position in Guardant Health in Q2 2020 and held it in 1 quarter.
  • Discovery Capital Management's Guardant Health position peaked at $6.08M in Q2 2020.
  • 346 funds tracked by Wall St. Rank held Guardant Health as of Q3 2020.

Based on Discovery Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.